These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22480206)

  • 21. Cutaneous manifestations of familial amyloidotic polyneuropathy.
    Rocha N; Velho G; Horta M; Martins A; Massa A
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):605-7. PubMed ID: 16164719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial amyloidotic polyneuropathy type I].
    Guevara C; Barrientos N; Flores A; Idiáquez J
    Rev Med Chil; 2003 Oct; 131(10):1179-82. PubMed ID: 14692309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
    J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.
    Takei Y; Gono T; Yazaki M; Ikeda S; Ikegami T; Hashikura Y; Miyagawa S; Hoshii Y
    Liver Transpl; 2007 Feb; 13(2):215-8. PubMed ID: 17029284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and genetic heterogeneity in familial amyloidotic polyneuropathy associated with variant transthyretin].
    Takahashi N; Ueno S
    Nihon Rinsho; 1993 Sep; 51(9):2435-9. PubMed ID: 8411724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
    Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
    J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial amyloid polyneuropathy.
    Planté-Bordeneuve V; Said G
    Lancet Neurol; 2011 Dec; 10(12):1086-97. PubMed ID: 22094129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study.
    Inês M; Coelho T; Conceição I; Duarte-Ramos F; de Carvalho M; Costa J
    Neuroepidemiology; 2018; 51(3-4):177-182. PubMed ID: 30153683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
    Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
    Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
    Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent syncope as persistently isolated feature of transthyretin amyloidotic polyneuropathy.
    Vita G; Mazzeo A; Di Leo R; Ferlini A
    Neuromuscul Disord; 2005 Mar; 15(3):259-61. PubMed ID: 15725588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A peripheral pathway to restless legs syndrome? Clues from familial amyloid polyneuropathy.
    Teodoro T; Viana P; Abreu D; Conceição I; Peralta R; Ferreira JJ
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1465-8. PubMed ID: 26508424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
    Cardoso I; Saraiva MJ
    FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
    J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody therapy for familial amyloidotic polyneuropathy.
    Su Y; Jono H; Torikai M; Hosoi A; Soejima K; Guo J; Tasaki M; Misumi Y; Ueda M; Shinriki S; Shono M; Obayashi K; Nakashima T; Sugawara K; Ando Y
    Amyloid; 2012 Jun; 19 Suppl 1():45-6. PubMed ID: 22506915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extremely Early Onset Transthyretin Familial Amyloid Polyneuropathy with a Leu55Pro Mutation: A Pediatric Case Report and Literature Review.
    Lee YJ; Oh J; Hwang SK; Lee EJ; Yang DH; Kim YJ; Kwon S; Hyun MC
    Neuropediatrics; 2019 Oct; 50(5):322-326. PubMed ID: 31319424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAP neuropathy and emerging treatments.
    Adams D; Théaudin M; Cauquil C; Algalarrondo V; Slama M
    Curr Neurol Neurosci Rep; 2014 Mar; 14(3):435. PubMed ID: 24482069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application to transthyretin analysis].
    Ueda M; Ando Y
    Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.